Literature DB >> 28642387

Texas signals support for unproven stem cell therapies.

Kelly Servick.   

Abstract

Mesh：

Year:  2017        PMID： 28642387     DOI： 10.1126/science.356.6344.1219

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  1 in total

Review 1.  Four Food and Drug Administration draft guidance documents and the REGROW Act: A litmus test for future changes in human cell- and tissue-based products regulatory policy in the United States?

Authors:  Kazuo Yano; Alessondra T Speidel; Masayuki Yamato
Journal:  J Tissue Eng Regen Med       Date:  2018-05-21       Impact factor: 3.963
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.